X0609 4 2026-09-02 0 0001384101 VERACYTE, INC. VCYT 0001649245 Febbo Phillip G. false 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific & Med Officer 1 Common Stock 2026-09-02 4 F 0 3639 44.88 D 146158 D Common Stock 2026-09-04 4 S 0 10405 42.8933 D 135753 D Common Stock 2026-09-04 4 S 0 2705 43.6618 D 133048 D Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. Represents weighted average sales price. Sale prices for the transactions range from $42.47 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Represents weighted average sales price. Sale prices for the transactions range from $43.475 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. /s/ Jonathan Wygant, as attorney-in-fact 2026-09-04